There are 2789 resources available
923P - Nivolumab in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN) progressing on/or after a platinum-based therapy: Interim analysis of a prospective French real-world study (ProNiHN)
Presenter: Christophe Le Tourneau
Session: ePoster Display
924P - HANNA: Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
Presenter: Harald Müller-Huesmann
Session: ePoster Display
871P - Uptake of concurrent chemoradiation in stage 2 nasopharyngeal cancer (NPC): A population-based outcomes study
Presenter: Teng Hwee Tan
Session: ePoster Display
872P - Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Christopher Black
Session: ePoster Display
873P - Early efficacy prediction of nasopharyngeal carcinoma based on 3D-ADC acquired during radiotherapy: A phase II prospective study
Presenter: Mei Feng
Session: ePoster Display
874P - Concurrent chemoradiation with cisplatin alone versus cisplatin and capecitabine in treatment of locally advanced head and neck cancer
Presenter: Abhishek Krishna
Session: ePoster Display
Resources:
Abstract
875P - Definitive chemo-IMRT in locally advanced head and neck squamous cell carcinoma (LAHN-SCC): An experience with geriatric patients
Presenter: Imtiaz Ahmed
Session: ePoster Display
611P - Pembrolizumab (pembro) monotherapy for docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): Updated analyses with 4 years of follow-up from cohorts 1-3 of the KEYNOTE-199 study
Presenter: Emmanuel Antonarakis
Session: ePoster Display